Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
Jan 2019
Historique:
accepted: 08 05 2018
pubmed: 20 6 2018
medline: 12 3 2019
entrez: 20 6 2018
Statut: ppublish

Résumé

To develop core outcome sets (COS) for studies evaluating interventions for (1) prevention and (2) treatment of postpartum haemorrhage (PPH), and recommendations on how to report the COS. A two-round Delphi survey and face-to-face meeting. Healthcare professionals and women's representatives. Outcomes were identified from systematic reviews of PPH studies and stakeholder consultation. Participants scored each outcome in the Delphi on a Likert scale between 1 (not important) and 9 (critically important). Results were discussed at the face-to-face meeting to agree the final COS. Consensus at the meeting was defined as ≥ 70% of participants scoring the outcome as critically important (7-9). Lectures, discussion and voting were used to agree how to report COS outcomes. Outcomes from systematic reviews and consultations. Both Delphi rounds were completed by 152/205 (74%) participants for prevention and 143/197 (73%) for treatment. For prevention of PPH, nine core outcomes were selected: blood loss, shock, maternal death, use of additional uterotonics, blood transfusion, transfer for higher level of care, women's sense of wellbeing, acceptability and satisfaction with the intervention, breastfeeding, and adverse effects. For treatment of PPH, 12 core outcomes were selected: blood loss, shock, coagulopathy, hysterectomy, organ dysfunction, maternal death, blood transfusion, use of additional haemostatic intervention, transfer for higher level of care, women's sense of wellbeing, acceptability and satisfaction with the intervention, breastfeeding, and adverse effects. Recommendations were developed on how to report these outcomes where possible. These COS will help standardise outcome reporting in PPH trials. Core outcome sets for PPH: nine core outcomes for PPH prevention and 12 core outcomes for PPH treatment.

Identifiants

pubmed: 29920912
doi: 10.1111/1471-0528.15335
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

83-93

Subventions

Organisme : Department of Health
ID : II-LA-0712-20007
Pays : United Kingdom
Organisme : Department of Health
ID : II-LA-0715-20008
Pays : United Kingdom
Organisme : Department of Health
ID : HTA/16/16/06
Pays : United Kingdom
Organisme : Department of Health
ID : 16/16/06
Pays : United Kingdom
Organisme : British Medical Association
ID : Strutt and Harper Grant
Organisme : World Health Organization
ID : 001
Pays : International

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2018 Royal College of Obstetricians and Gynaecologists.

Auteurs

S Meher (S)

Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.
Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

A Cuthbert (A)

Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.

J J Kirkham (JJ)

Department of Biostatistics, University of Liverpool, Liverpool, UK.

P Williamson (P)

Department of Biostatistics, University of Liverpool, Liverpool, UK.

E Abalos (E)

Centro Rosarino de Estudios Perinatales (CREP), Rosario, Argentina.

N Aflaifel (N)

Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.

Z A Bhutta (ZA)

Division of Women and Child Health, Aga Khan University, Karachi, Pakistan.
The Hospital for Sick Children, Toronto, Canada.

A Bishop (A)

Cochrane Pregnancy and Childbirth Group, University of Liverpool, Liverpool, UK.

J Blum (J)

Gynuity Health Projects, New York, NY, USA.

P Collins (P)

Institute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.

D Devane (D)

HRB-Trials Methodology Research Network, School of Nursing and Midwifery, National University of Ireland Galway, Galway, Ireland.

A-S Ducloy-Bouthors (AS)

Centre Hospitalier Regional Universitaire de Lille, Lille, France.

B Fawole (B)

Department of Obstetrics and Gynaecology, College of Medicine, University of Ibadan, Ibadan, Nigeria.

A M Gülmezoglu (AM)

The UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland.

K Gutteridge (K)

Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.

G Gyte (G)

Cochrane Pregnancy and Childbirth Group, University of Liverpool, Liverpool, UK.

Cse Homer (C)

Centre for Midwifery, Child and Family Health, University of Technology Sydney, Sydney, NSW, Australia.

S Mallaiah (S)

Liverpool Women's Hospital, Liverpool, UK.

J M Smith (JM)

Jhpiego/Johns Hopkins University, Baltimore, MD, USA.

A D Weeks (AD)

Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.

Z Alfirevic (Z)

Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH